Testicular Cancer is when malignant cancer cells develop in one or both of the testicles in the germ cells. Testicular cancer is the most common cancer in men between the ages of 20-35 years old and is most commonly found in Caucasian men. Risk for developing testicular cancer are having an undescended testicle, family history, and abnormal development of the testicles. There are two main types of testicular cancers: seminomas and nonseminomas. Nonseminomas grow more rapidly and are less sensitive to radiation compared to seminomas. Testicular cancer can spread throughout the body through the tissues, the lymph system, and the blood. In stage I of testicular cancer, cancer has formed. Stage I is divided into three parts: stage IA, stage IB, and stage IS. Stage IA is when the cancer is localized to the testicle and epididymis and may have spread to the inner layer of the membrane surrounding the testicle, yet all the tumor marker levels remain normal. Stage IB occurs when the cancer is in the testicle and epididymis but has spread to the outer layer of the membrane of the testicle or to blood/lymph vessels in the testicle, but all tumor markers are normal. Stage IC occurs when the cancer is found within the testicle, spermatic cord, or the scrotum and either all tumor marker levels are above normal or at least one is moderately high.
Stage I Testicular Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage I Testicular Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 928 products for the study of Stage I Testicular Cancer that can be applied to Western Blot, Chromatin Immunoprecipitation, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Chromatin Immunoprecipitation (ChIP), Immunohistochemistry from our catalog of antibodies and ELISA kits.